MX2011007641A - Nuevos compuestos heterociclicos como inhibidores de metap-2. - Google Patents
Nuevos compuestos heterociclicos como inhibidores de metap-2.Info
- Publication number
- MX2011007641A MX2011007641A MX2011007641A MX2011007641A MX2011007641A MX 2011007641 A MX2011007641 A MX 2011007641A MX 2011007641 A MX2011007641 A MX 2011007641A MX 2011007641 A MX2011007641 A MX 2011007641A MX 2011007641 A MX2011007641 A MX 2011007641A
- Authority
- MX
- Mexico
- Prior art keywords
- inhibitors
- metap
- heterocyclic compounds
- novel heterocyclic
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Los compuestos de la fórmula I.(ver fórmula(I)) en donde D, X, Y, Z, R y R1 tienen los significados indicados en la reivindicación 1, son inhibidores de la metionina-amino-peptidasa y se pueden usar para el tratamiento de tumores.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102009005193A DE102009005193A1 (de) | 2009-01-20 | 2009-01-20 | Neue heterocyclische Verbindungen als MetAP-2 Inhibitoren |
PCT/EP2009/009218 WO2010083870A1 (de) | 2009-01-20 | 2009-12-22 | Neue heteroclyclische verbindungen als metap-2 inhibitoren |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2011007641A true MX2011007641A (es) | 2011-09-06 |
Family
ID=42210278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011007641A MX2011007641A (es) | 2009-01-20 | 2009-12-22 | Nuevos compuestos heterociclicos como inhibidores de metap-2. |
Country Status (16)
Country | Link |
---|---|
US (1) | US8546406B2 (es) |
EP (1) | EP2379558B1 (es) |
JP (1) | JP5619025B2 (es) |
KR (1) | KR20110112434A (es) |
CN (1) | CN102292339B (es) |
AR (1) | AR075035A1 (es) |
AU (1) | AU2009337953B2 (es) |
BR (1) | BRPI0924033A2 (es) |
CA (1) | CA2749970C (es) |
DE (1) | DE102009005193A1 (es) |
EA (1) | EA201101090A1 (es) |
ES (1) | ES2575687T3 (es) |
IL (1) | IL213935A (es) |
MX (1) | MX2011007641A (es) |
SG (1) | SG174118A1 (es) |
WO (1) | WO2010083870A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008027574A1 (de) * | 2008-06-10 | 2009-12-17 | Merck Patent Gmbh | Neue Pyrrolidinderivate als MetAP-2 Inhibitoren |
BR112021014220A2 (pt) * | 2019-01-22 | 2022-01-18 | Merck Patent Gmbh | Derivados heterocíclicos |
WO2023196540A1 (en) * | 2022-04-06 | 2023-10-12 | Vanderbilt University | Articles and methods for inhibiting methionine aminopeptidase activity |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3037980A (en) * | 1955-08-18 | 1962-06-05 | Burroughs Wellcome Co | Pyrrolopyrimidine vasodilators and method of making them |
FR2448542A1 (fr) * | 1979-02-06 | 1980-09-05 | Landerlan Sa Lab | Derives de triazolapyrimidine utiles comme medicaments |
US5747469A (en) | 1991-03-06 | 1998-05-05 | Board Of Regents, The University Of Texas System | Methods and compositions comprising DNA damaging agents and p53 |
US6395733B1 (en) * | 1995-06-07 | 2002-05-28 | Pfizer Inc | Heterocyclic ring-fused pyrimidine derivatives |
ES2203642T3 (es) * | 1995-06-07 | 2004-04-16 | Pfizer Inc. | Derivados de pirimidina heterociclicos con anillos condensados. |
PA8474101A1 (es) * | 1998-06-19 | 2000-09-29 | Pfizer Prod Inc | Compuestos de pirrolo [2,3-d] pirimidina |
GB9904387D0 (en) | 1999-02-25 | 1999-04-21 | Pharmacia & Upjohn Spa | Antitumour synergistic composition |
UY26664A1 (es) | 2000-04-14 | 2001-11-30 | Abbott Lab | Hidrazidas y alcoxiamidas inhibidoras de la angiogénesis. |
US20070161570A1 (en) | 2000-11-01 | 2007-07-12 | Praecis Pharmaceuticals, Inc. | Methionine aminopeptidase-2 inhibitors and methods of use thereof |
WO2002081415A2 (en) | 2001-04-03 | 2002-10-17 | Smithkline Beecham Corporation | Method for inhibiting metap2 |
JP4306206B2 (ja) * | 2001-09-04 | 2009-07-29 | 住友化学株式会社 | イミダゾ[1,2−a]ピリミジン、その用途およびその製造中間体 |
WO2004108136A1 (en) * | 2003-06-04 | 2004-12-16 | Vernalis (Cambridge) Limited | Triazolo `1 , 5-a!pyrimidines and their use in medicine |
CN1933844A (zh) * | 2003-12-22 | 2007-03-21 | 吉里德科学公司 | 激酶抑制剂膦酸酯缀合物 |
US20050187389A1 (en) * | 2004-01-13 | 2005-08-25 | Ambit Biosciences Corporation | Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases |
AR053090A1 (es) * | 2004-07-20 | 2007-04-25 | Osi Pharm Inc | Imidazotriazinas como inhibidores de proteina quinasas y su uso para la preparacion de medicamentos |
CN101500574A (zh) * | 2005-03-15 | 2009-08-05 | Irm责任有限公司 | 用作蛋白激酶抑制剂的化合物和组合物 |
DE102005037733A1 (de) | 2005-08-10 | 2007-02-15 | Merck Patent Gmbh | Adeninderivate |
WO2008012635A2 (en) * | 2006-07-26 | 2008-01-31 | Pfizer Products Inc. | Amine derivatives useful as anticancer agents |
DE102008027574A1 (de) * | 2008-06-10 | 2009-12-17 | Merck Patent Gmbh | Neue Pyrrolidinderivate als MetAP-2 Inhibitoren |
-
2009
- 2009-01-20 DE DE102009005193A patent/DE102009005193A1/de not_active Withdrawn
- 2009-12-22 MX MX2011007641A patent/MX2011007641A/es not_active Application Discontinuation
- 2009-12-22 CA CA2749970A patent/CA2749970C/en active Active
- 2009-12-22 JP JP2011546612A patent/JP5619025B2/ja active Active
- 2009-12-22 KR KR1020117019386A patent/KR20110112434A/ko not_active Application Discontinuation
- 2009-12-22 CN CN200980154939.0A patent/CN102292339B/zh active Active
- 2009-12-22 BR BRPI0924033A patent/BRPI0924033A2/pt not_active Application Discontinuation
- 2009-12-22 EA EA201101090A patent/EA201101090A1/ru unknown
- 2009-12-22 EP EP09796971.1A patent/EP2379558B1/de active Active
- 2009-12-22 AU AU2009337953A patent/AU2009337953B2/en active Active
- 2009-12-22 ES ES09796971.1T patent/ES2575687T3/es active Active
- 2009-12-22 WO PCT/EP2009/009218 patent/WO2010083870A1/de active Application Filing
- 2009-12-22 SG SG2011050564A patent/SG174118A1/en unknown
- 2009-12-22 US US13/145,422 patent/US8546406B2/en active Active
-
2010
- 2010-01-20 AR ARP100100121A patent/AR075035A1/es unknown
-
2011
- 2011-07-05 IL IL213935A patent/IL213935A/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CA2749970C (en) | 2017-11-28 |
EP2379558B1 (de) | 2016-03-23 |
US20110281859A1 (en) | 2011-11-17 |
CN102292339B (zh) | 2015-01-28 |
AU2009337953A1 (en) | 2011-09-01 |
BRPI0924033A2 (pt) | 2016-01-26 |
KR20110112434A (ko) | 2011-10-12 |
ES2575687T3 (es) | 2016-06-30 |
EP2379558A1 (de) | 2011-10-26 |
IL213935A (en) | 2017-06-29 |
JP5619025B2 (ja) | 2014-11-05 |
JP2012515731A (ja) | 2012-07-12 |
AU2009337953B2 (en) | 2016-02-11 |
WO2010083870A1 (de) | 2010-07-29 |
EA201101090A1 (ru) | 2012-03-30 |
IL213935A0 (en) | 2011-07-31 |
CA2749970A1 (en) | 2010-07-29 |
US8546406B2 (en) | 2013-10-01 |
AR075035A1 (es) | 2011-03-02 |
SG174118A1 (en) | 2011-10-28 |
CN102292339A (zh) | 2011-12-21 |
DE102009005193A1 (de) | 2010-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010003475A8 (de) | Neue pyrrolidinderivate als metap-2 inhibitoren | |
MX2013004004A (es) | Pirrolidinonas como inhibidores de metionina aminopeptidasa (metap-2). | |
PH12014501964A1 (en) | Cyclic amides as metap-2 inhibitors | |
MX2010009416A (es) | Compuestos heterociclicos como inhibidores de cxcr2. | |
MX2011011094A (es) | Derivados de prolina como inhibidores de catepsina. | |
MX336381B (es) | Boronatos como inhibidores de arginasa. | |
JO3025B1 (ar) | الأندازولات المستبدلة بالأوكسازول كمثبطات كيناز pi3 | |
NZ597517A (en) | 5-fluoropyrimidinone derivatives | |
EA201200119A1 (ru) | Гетероциклические соединения в качестве ингибиторов аутотаксина | |
MY155517A (en) | Heterocyclic derivatives | |
EA201100880A1 (ru) | Бензонафтиридиновые соединения в качестве ингибиторов аутотаксина | |
MX2012004114A (es) | Compuestos heterociclicos utiles como inhibidores de proteina cinasa-1 dependiente de 3-fosfoinositido (pdk1). | |
EA201170832A1 (ru) | Пуриновые соединения | |
NZ589844A (en) | Thiophene or thiazole derivatives and their use as phosphatidylinositol 3-kinase (PI3K) inhibitors | |
EA201200323A1 (ru) | Соединения и композиции, как ингибиторы протеинкиназы | |
MX2012006805A (es) | Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa. | |
GEP20156242B (en) | 2-arylimidazole derivatives as pde10a enzyme inhibitors | |
MX2010010406A (es) | Tetrahidrofenantridinonas y tetrahidrociclopentaquinolinonas como inhibidores de la polimerizacion de poli(adp-ribosa)polimerasa-1 y tubulina. | |
MX345127B (es) | Derivados de tiazol. | |
MX2010003365A (es) | Derivados de tiazol para el tratamiento de cancer. | |
NZ597570A (en) | N1-acyl-5-fluoropyrimidinone derivatives | |
NZ597483A (en) | N1-substituted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives | |
MX2011007165A (es) | Derivados de piridazinona. | |
MX346090B (es) | Derivados de pirrolidina usados como inhibidores de catepsina. | |
MX2010010876A (es) | Piperidinas sustituidas como compuestos terapeuticos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |